Refine by
Hematology Malignancies Equipment Supplied In Denmark
1 equipment items found
by:Genmab A/S based inCopenhagen V, DENMARK
In June 2019, Genmab entered into an exclusive worldwide license and option agreement with Janssen Biotech Inc. to develop and commercialize HexaBody®-CD38. In preclinical models of hematological malignancies, HexaBody®-CD38 demonstrated enhanced complement-dependent cytotoxicity and potent anti-tumor ...
